SalubrisBio

Gaithersburg, United States

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

$35.0M raised

Apr 2024

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has SalubrisBio raised?

SalubrisBio has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in April 2024.

Who are SalubrisBio's investors?

SalubrisBio's investors include Shenzhen Salubris Pharmaceuticals.

Where is SalubrisBio headquartered?

SalubrisBio is headquartered in Gaithersburg, United States.

What does SalubrisBio do?

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

What stage is SalubrisBio at?

SalubrisBio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 22, 2024.

MLA

"SalubrisBio — Funding & Investors." VCBacked, April 22, 2024, https://www.vcbacked.co/company/salubrisbio. Accessed July 2, 2026.

APA

VCBacked. (2024). SalubrisBio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/salubrisbio

Wikipedia (cite web)

{{cite web |title=SalubrisBio — Funding & Investors |url=https://www.vcbacked.co/company/salubrisbio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 22, 2024.